Drawing for DUOVIAL

USPTO serial 79243423

DUOVIAL

Reviewed by CopyMark Law Group

Reg. 6015601Status 700Registered
Filing date
Status date
Registration date
Mar 24, 2020
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DUOVIAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia B. Lisi

Julia B. Lisi DORSEY & WHITNEY LLPSuite 150050 South 6th StreetMinneapolis, MN 55402-1498

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cosmetics and toiletry preparations; non-medicated dentifrices; bleaching preparations and other substances for household purposes, namely, laundry bleach, laundry wax, laundry detergents, laundry soap, and liquid laundry detergents, all for laundry use; cleaning, polishing, scouring and abrasive preparationsACTIVE—
005Pharmaceuticals, medical and veterinary preparations, namely, biologics and biopharmaceuticals in the form of vaccines for the treatment of cancers, rheumatoid diseases and disorders, skin diseases and disorders, immune system diseases and disorders, anemia and diseases of the blood, gastrointestinal diseases and disorders, and neurological diseases and disorders, blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors; therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue used to protect against infectious disease and to treat cancers, rheumatoid diseases and disorders, skin diseases and disorders, immune system diseases and disorders, anemia and diseases of the blood, gastrointestinal diseases and disorders, and neurological diseases and disorders; sanitary preparations for medical purposes; dietetic food and substances in the nature of dietetic food adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; disinfectants; preparations for destroying vermin; fungicides, herbicidesACTIVE—
009Scientific apparatus and instruments, namely, laboratory glassware, measuring glassware and graduated glassware for the development and preparation of vials containing pharmaceutical, medical and veterinary preparations; vials for laboratory use, namely, laboratory glassware; vials for scientific purposes, namely, laboratory glassware; laboratory glassware; biological glassware, namely, laboratory glassware; glass containers for laboratory use, namely, laboratory glassware; structural parts and fittings for all of the aforesaidACTIVE—
010Surgical apparatus and instruments; medical and dental apparatus, namely, infusion and injection devices for administering drugs, medical apparatus for intravenous administration of pharmaceutical preparations, and medical apparatus for introducing pharmaceutical preparations into the human body; veterinary apparatus and instruments, namely, infusion and injection devices for administering drugs, medical apparatus for intravenous administration of pharmaceutical preparations, and medical apparatus for introducing pharmaceutical preparations into animals; therapeutic and assistive devices adapted for the disabled, namely, medical dosage devices adapted for the delivery of liquid and powder preparations to the disabled; structural parts and fittings for all of the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 24, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 16, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 16, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 16, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 16, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 25, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 4, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 4, 2020FIMPFINAL DISPOSITION PROCESSED—
Jun 24, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 3, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 24, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 18, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 18, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 7, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 29, 2019EXPTEXPARTE APPEAL TERMINATED—
Nov 29, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 27, 2019ALIEASSIGNED TO LIE—
Nov 21, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 21, 2019EXPIEX PARTE APPEAL-INSTITUTED—
Nov 21, 2019JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Nov 21, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB—
May 24, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 24, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 24, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2019RFNPREFUSAL PROCESSED BY IB—
Dec 19, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 19, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 12, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 11, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2018DOCKASSIGNED TO EXAMINER—
Oct 26, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 22, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance